Keyphrases
Periodontitis
100%
Epigallocatechin-3-gallate
100%
Mucoadhesive
100%
Oral Patch
100%
Osteoprotegerin
36%
Nuclear Factor kappa
36%
Lower Incisor
18%
Porphyromonas Gingivalis (P. gingivalis)
9%
Topical Therapy
9%
Active Ingredients
9%
Gingiva
9%
Anti-inflammatory Effect
9%
Immunohistochemistry
9%
Alveolar Bone
9%
Rattus Novergicus
9%
Therapeutic Potential
9%
Nuclear factor-B
9%
Colony Forming Units
9%
Doxycycline
9%
Mucosa
9%
Oral Tissues
9%
Patch Group
9%
Medicine and Dentistry
Epigallocatechin Gallate
100%
Periodontitis
100%
Receptor
71%
Nuclear Factor
71%
Osteoprotegerin
57%
Doxycycline
28%
Mandibular Central Incisor
28%
Alveolar Bone
14%
Topical Agent
14%
Antiinfective Agent
14%
Immunohistochemistry
14%
Gum (Oral Cavity)
14%
Antiinflammatory Activity
14%
Mucosa
14%
Porphyromonas gingivalis
14%
Alternative Complement Pathway C3 C5 Convertase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Periodontitis
100%
Epigallocatechin Gallate
100%
Receptor
71%
Nuclear Factor
71%
Osteoprotegerin
57%
Doxycycline
28%
Antiinfective Agent
14%
Topical Agent
14%
Antiinflammatory Activity
14%
Porphyromonas gingivalis
14%
Alternative Complement Pathway C3 C5 Convertase
14%